ACE inhibitors during the first trimester MIGHT increase the risk of birth defects
July 2006
A new study suggests that using ACE inhibitors during the first trimester MIGHT increase the risk of birth defects.
This is a surprise.
We know that exposure to ACE inhibitors and ARBs during the second and third trimesters increases the risk of fetal death. But experts are not yet convinced that ACE inhibitors are dangerous during the first trimester.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote